CV Sciences, Inc. (CVSI)
$0.01+0.00%Close
SELLRECOVERY · day 1
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $2M
- Beta
- 0.43
- P/E (TTM)
- -1.44
- Short % float
- 0.01%
- Days to cover
- 1.0
- SI change
- +123.1%
- 1W
- +0.00%
- 1M
- -50.00%
- vs SPY 1W
- +0.14%
- vs SPY 1M
- -52.51%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
FUNDAMENTALS
[SCORES & PROFILE]
- FUND
- 0
- VALUE
- 3
- GROWTH
- 26
- GARP
- 2
- TYPE
- Balanced
Composite of Value · Growth · GARP
ROIC-79.2%
REV YoY-
ROE-132.1%
EPS YoY-
ROA-30.8%
GROSS49
OP-12
NET-16
[VALUATION]
P/E TTM-1.44
P/E FWD-
SECTOR PE20.48
INDUSTRY PE19.11
P/B1.96
P/FCF-
EV/EBITDA-3.29
EV/EBIT-
PEG-
FCF YIELD-
RISK
INT COV-
D/E79.76
ALTMAN Z-
CURR RATIO0.99
ND/EBITDA-
BETA0.43
Company news
FAQ
- What is LOPJLB’s current signal on CVSI?
- LOPJLB’s latest quantitative signal on CV Sciences, Inc. (CVSI) is SELL in a RECOVERY regime. Signals are updated daily.
- What market regime is CVSI in?
- CV Sciences, Inc. (CVSI) is currently classified in the RECOVERY HMM market regime on LOPJLB.
- What does CV Sciences, Inc. (CVSI) do?
- CV Sciences, Inc. functions as a life sciences organization primarily operating across North America. Its business activities are organized into two distinct divisions: Consumer Products and Specialty Pharmaceutical. The Consumer Products division focuses on the creation, manufacturing, and commercialization of plant-derived dietary supplements and cannabidiol (CBD) products sourced from hemp. …